Impact of the Sars-Cov-2 outbreak on the initial clinical presentation of new solid cancer diagnoses: a systematic review and meta-analysis.

ORs for other cancer types did not reach statistical significance: 0.79 (0.18-3.52) for lung cancer, 1.15 (0.89-1.49) for colorectal cancer, 1.45 (0.62-3.42) for other types of digestive cancers, 2.26 (0.51-10.05) for prostate cancer, 12.07 (0.57-253.68) for genito-urinary cancer (one study only), 2.49 (0.00-84,469.69) for melanomas, and 1.01 (0.59-1.75) for other types of cancers (X 2 = 24.60, p <0.01) (Fig. 4 a).

also in 111,027 other papers